Economic evaluation of cholinesterase inhibitor therapy for dementia: comparison of Alzheimer's disease and Dementia with Lewy bodies.
OBJECTIVE: To assess the cost effectiveness of cholinesterase inhibitor (ChEI) treatment in patients with Alzheimer's disease (AD) and Dementia with Lewy bodies (DLB). METHOD: We used 4-month open label follow-up data from routine memory clinic patients. There were 852 patients with AD and 112...
Автори: | Gustavsson, A, Van Der Putt, R, Jönsson, L, Mcshane, R |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
2009
|
Схожі ресурси
Схожі ресурси
-
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
за авторством: Rolinski, M, та інші
Опубліковано: (2012) -
Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.
за авторством: Ballard, C, та інші
Опубліковано: (2007) -
Cholinesterase inhibitor treatment increases phosphotau accumulation in Alzheimer's disease but reduces A beta in dementia with Lewy bodies
за авторством: Chalmers, K, та інші
Опубліковано: (2008) -
Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology.
за авторством: McShane, R, та інші
Опубліковано: (2001) -
Depression in dementia with Lewy bodies: A comparison with Alzheimer's disease.
за авторством: Pai-Yi Chiu, та інші
Опубліковано: (2017-01-01)